Liver cirrhosis-effect on QT interval and cardiac autonomic nervous system activity

Table 2 Clinical characteristics and associated laboratory test results of patients with cirrhos

	n	%
Child-Pugh score	7 (5-9)
Child-Pugh Grade A (score: 5-6)	22	43.1
B (score: 7-9)	18	35.3
C (score: 10-15)	11	21.6
MELD score	29.8 (14.4-39.6)
Decompensated cirrhosis	29	56.9
Alcohol	17	33.3
Viral Hepatitis	24	47.1
Hepatitis Β	10	19.6
Hepatitis C	12	23.5
Hepatitis B + C	2	3.9
Other	10	19.6
Systematic use of beta-blockers (yes)	16	31.4
Ascites (yes)	23	45.1
Esophageal varices (yes)	28	54.9
Liver biopsy	25	49.0
Histologic activity index	8.6 ± 2.9
Disease duration (yr)	3 (0.8-7)
INR	1.41 ± 0.41
AST (U/L)	43.0 (34.0-66.0)
ALT (U/L)	36.0 (24.0-50.0)
ALP (U/L)	262.7 ± 121.8
LDH (U/L)	392.4 ± 123.0
γ-GT (U/L)	39.0 (28.0-76.0)
Cholesterol (mg/dL)	175.9 ± 56.2
Triglycerides(mg/dL)	76.0 (50.0-108.0)
Total bilirubin (mg/dL)	1.25 (0.68-2.29)
Direct bilirubin (mg/dL)	0.75 (0.30-1.13)
Total proteins (g/dL)	7.5 ± 0.8
Albumin (g/dL)	4.0 ± 0.8
Blood potassium (meq/L)	4.2 ± 0.4
Blood sodium (meq/L)	138.1 ± 4.6

Data are presented as mean ± SD or as n (%) or as median value (interquartile range). MELD: Model for end-stage liver disease.